Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
Published on: September 27, 2024
Serum adenosine deaminase activity in cutaneous anthrax
Mahmut Sunnetcioglu1, Sevdegul Karadas2, Mehmet Aslan1
1Department of Infectious Diseases and Clinical Microbiology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Serum adenosine deaminase (ADA) activity is significantly elevated in cutaneous anthrax patients compared to healthy individuals. This finding suggests ADA may serve as a valuable biomarker for diagnosing cutaneous anthrax.
Area of Science:
- Biochemistry
- Immunology
- Infectious Diseases
Background:
- Adenosine deaminase (ADA) activity is linked to inflammatory conditions.
- Limited data exists on ADA activity in cutaneous anthrax.
Purpose of the Study:
- Investigate serum ADA activity in patients diagnosed with cutaneous anthrax.
- Determine the potential of ADA as a biomarker for cutaneous anthrax.
Main Methods:
- Enrolled 16 patients with cutaneous anthrax and 17 healthy controls.
- Measured serum ADA activity, complete blood counts (leukocytes, lymphocytes, neutrophils, monocytes), erythrocyte sedimentation rate, and C-reactive protein levels.
Main Results:
- Serum ADA activity was significantly higher in the cutaneous anthrax group compared to controls (p<0.001).
- A positive correlation was found between ADA activity and lymphocyte counts in patients (r=0.589, p=0.021).
Conclusions:
- Serum ADA activity is a potential biochemical marker for cutaneous anthrax.
- Elevated ADA levels correlate with specific immune cell counts in cutaneous anthrax patients.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
05:53A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
Published on: December 7, 2021